Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$51.65−1.52 (-2.86%)
Close on Nov 17, 2026Market cap $7.18BP/E –Yield –
Cytokinetics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cytokinetics's market cap was $7.28M on Nov 11, 2026, against $8.11M a year earlier. Over the last 5 years it ranged from $2.44M to $8.10B, with a median of $5.80M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.28M | -3.7% |
| 2025 | Dec 31, 2025 | $7.56M | +50.3% |
| 2024 | Dec 31, 2024 | $5.03M | -36.8% |
| 2023 | Dec 29, 2023 | $7.97M | +99.5% |
| 2022 | Dec 30, 2022 | $3.99M | +19.1% |
| 2021 | Dec 31, 2021 | $3.35M | +162.0% |
| 2020 | Dec 31, 2020 | $1.28M | -99.7% |
| 2019 | Apr 30, 2019 | $482.61M | +40.8% |
| 2018 | Dec 31, 2018 | $342.80M | -21.9% |
| 2017 | Dec 29, 2017 | $438.98M | -10.8% |
| 2016 | Dec 30, 2016 | $492.28M | +21.4% |
| 2015 | Dec 31, 2015 | $405.39M | +38.2% |
| 2014 | Dec 31, 2014 | $293.24M | +52.9% |
| 2013 | Dec 31, 2013 | $191.77M | +104.0% |
| 2012 | Dec 31, 2012 | $93.99M | +35.5% |
| 2011 | Dec 30, 2011 | $69.39M | -42.7% |
| 2010 | Dec 31, 2010 | $121.14M | – |
See a number that looks wrong?